Currently predicting for Mon, 1 Apr 2024

Trading levels for ADXS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.747 16.67 %
R2 0.716 11.89 %
R1 0.697 8.94 %
Current price: 0.640
Support S1 0.636 -0.608 %
S2 0.617 -3.56 %
S3 0.587 -8.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.788 23.13 %
R2 0.680 6.25 %
R1 0.670 4.69 %
Current price 0.640
Support S1 0.627 -2.08%
S2 0.600 -6.25%
S3 0.590 -7.81%

ADXS Predictions History

2 years ago
JS predicted that ADXS for 2021-07-26 is going $0.406 (-0.56%)

2 years ago
RamboRex3000 predicted that ADXS for 2021-07-26 is going $0.400 (-4.76%)

2 years ago
timsmithinvesting.223838 predicted that ADXS for 2021-07-07 is going

Rank:

2 years ago
Cherie Lynn Auletta predicted that ADXS for 2021-07-07 is going

Rank:

2 years ago
Omar.Elgusbi.87144 predicted that ADXS for 2021-07-07 is going

Rank:

3 years ago
JS predicted that ADXS for 2021-01-20 is going $0.698 (0.87%)

3 years ago
Baltzera predicted that ADXS for 2021-01-20 is going

3 years ago
JS predicted that ADXS for 2021-01-19 is going $0.593 (-2.79%)

3 years ago
NathanAnderson predicted that ADXS for 2021-01-19 is going

Rank:

3 years ago
JS predicted that ADXS for 2020-11-12 is going $0.393 (-0.33%)

Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT